CN100396321C - Preparation of Chinese traditional medicine for treating hyperosteogeny - Google Patents

Preparation of Chinese traditional medicine for treating hyperosteogeny Download PDF

Info

Publication number
CN100396321C
CN100396321C CNB2006100427267A CN200610042726A CN100396321C CN 100396321 C CN100396321 C CN 100396321C CN B2006100427267 A CNB2006100427267 A CN B2006100427267A CN 200610042726 A CN200610042726 A CN 200610042726A CN 100396321 C CN100396321 C CN 100396321C
Authority
CN
China
Prior art keywords
radix
hyperosteogeny
herba
rhizoma
medicine preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006100427267A
Other languages
Chinese (zh)
Other versions
CN1872310A (en
Inventor
张岚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006100427267A priority Critical patent/CN100396321C/en
Publication of CN1872310A publication Critical patent/CN1872310A/en
Application granted granted Critical
Publication of CN100396321C publication Critical patent/CN100396321C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention belongs to a Chinese traditional medicine preparation in a medicine preparation for treating hyperosteogeny, which is manufactured from raw materials of the following proportion by weight: 20 to 40% of wolfberry bark, 15 to 25% of eucommia bark, 20 to 40% of fennel, 15 to 25% of Chinese angelica, 10 to 20% of boniness, 35 to 65% of prepared rhizome of rehmannia, 20 to 40% of drynaria, 15 to 25% of broomrape, 10 to 20% of radish seed, 15 to 25% of chuanxiong rhizome, 20 to 40% of pyrola herb, 35 to 65% of spatholobus stem, 15 to 25% of epimedium, 20 to 40% of Chinese yam, 15 to 25% of red peony root, 15 to 25% of peach kernel, 10 to 16% of notoginseng powder, 10 to 20% of pangolin, and 15 to 25% of cyathula root. The total effective rate of the present invention for treating hyperosteogeny can reach 96.2% according to clinical results.

Description

A kind of Chinese medicine preparation for the treatment of hyperosteogeny
Technical field
The invention belongs to a kind of pharmaceutical product, particularly a kind of Chinese medicine preparation that is used for the treatment of hyperosteogeny.
Background technology
Hyperosteogeny is commonly considered as a kind of performance of articular cartilage degeneration.Though be mainly in middle-aged and elderly people (crowd has reaching more than 90% of hyperosteogeny phenomenon more than 40 years old),, the trend of the rejuvenation of turning to arranged at present owing to the change of people people's living habit causes long-term sitting posture and motion very few.Hyperosteogeny is common in this class weight-bearing joint of cervical vertebra, lumbar vertebra, hip knee joint and sufficient root.Not only unusual pain after the hyperosteogeny generation bony spur, and compressing blood vessel and nerve cause blood obstructed, produce even more serious consequence and cause disability.
Doctor trained in Western medicine mainly adopts the anti-inflammatory type medicine to come alleviating pain to the treatment of hyperosteogeny, can not reach the purpose of elimination.Take the physiotherapy of massaging and drawing also to this and certain mitigation is arranged, but need adhere to massage for a long time.Not only the patient suffering is big but also costly for the method for operation.Existing Chinese medicine such as bony spur tablet, resisting hyperosteogeny sheet, ZHUANGGU GUANJIE WAN and the bony spur painful liquid that disappears all exists and takes effect slow and excessive and cause side effect such as patient's anorexia and stomachache to gastrointestinal stimulation.
Summary of the invention
The object of the invention provides the Chinese medicine preparation of a kind of course of treatment than short treatment hyperosteogeny.
The traditional Chinese medical science thinks that hyperosteogeny one is that deficiency of both the liver and kidney, medicine are tired and hinders, and spasm of muscles and vessels, gos deep into muscles and bones and causes the cloudy skeleton that stagnates of congestion, grain, QI-blood circulation to be obstructed and to form wind-cold damp pathogen; The 2nd, plain body weakness, insufficiency of vital energy and blood is attacked passages through which vital energy circulates in the wind-cold damp pathogen, and the retardance meridians cause qi and blood stagnation, and are obstructed through then.Also think kidney governing bones, liver governing tendons simultaneously, because people's naturally-aged, all empty muscles and bones mistakes of Liver and kidney are supported, add " prolonged standing injuring bones ", " prolonged walking injuring tendons " causes the damage of the long-pending base property of osteoarthrosis, the destruction of articular cartilage, coming off of cartilage fragment, the invasion and attack of wind-cold damp pathogen, grain is obstructed, stagnation of QI-blood, accumulate in the course of time and do not go, it is turbid to turn to expectorant, with the congestion gluing, spleen resistance bone joint forms muscles and bones spleen disease.
The present invention is according to the research of motherland's theory of Chinese medical science to the formation mechanism of hyperosteogeny, and definite Chinese medicine preparation is made by the raw material of following weight portion:
Cortex Lycii 20-40, Cortex Eucommiae 15-25, Fructus Foeniculi 20-40, Radix Angelicae Sinensis 15-25, Fructus Amomi Rotundus 10-20, Radix Rehmanniae Preparata 35-65, Rhizoma Drynariae 20-40, Herba Cistanches 15-25, Semen Raphani 10-20, Rhizoma Chuanxiong 15-25, Herba Pyrolae 20-40, Caulis Spatholobi 35-65, Herba Epimedii 15-25, Rhizoma Dioscoreae 20-40, Radix Paeoniae Rubra 15-25, Semen Persicae 15-25, Radix Notoginseng powder 10-16, Squama Manis 10-20, Radix Cyathulae 15-25.
The raw material that the preferential prescription of recommending of the present invention is following weight portion is made:
Cortex Lycii 25-35, Cortex Eucommiae 18-22, Fructus Foeniculi 25-35, Radix Angelicae Sinensis 18-22, Fructus Amomi Rotundus 13-17, Radix Rehmanniae Preparata 45-55, Rhizoma Drynariae 25-35, Herba Cistanches 18-22, Semen Raphani 13-17, Rhizoma Chuanxiong 18-22, Herba Pyrolae 25-35, Caulis Spatholobi 45-55, Herba Epimedii 18-22, Rhizoma Dioscoreae 25-35, Radix Paeoniae Rubra 18-22, Semen Persicae 18-22, Radix Notoginseng powder 11-15, Squama Manis 13-17, Radix Cyathulae 18-22.
After adding 0.2 part of Moschus on the above-mentioned prescription for oral administration basis, be mixed and made into external preparation.
The medicines that adopt kidney invigorating and YANG supporting, bone and muscle strengthening and nourishing the liver in the present invention's prescription more, be equipped with the disappear medicine of painful abdominal mass of the relaxing muscles and tendons and activating QI and blood in the collateral of enriching blood, circulation of qi promoting removing dampness, simultaneously at the medicine that adds blood circulation promoting and blood stasis dispelling, wind-expelling pain-stopping, each drug synergism, can improve the blood supply and the circulation of internal organs and limbs effectively, improve and regulate the permeability of microcirculation blood capillary, infiltration cortex muscular tissue plays metabolism, circulation of qi promoting, removing blood stasis with potent drugs, blood stasis dispelling, analgesic effect.
Each herbal medicine effect is as follows among the present invention:
Cortex Lycii: removing heat from blood moves back steaming, and lung-fire purifies the blood;
The Cortex Eucommiae: invigorating the liver and kidney, bone and muscle strengthening, controlling nocturnal emission with astringent drugs is calmed the nerves, blood pressure lowering;
Fructus Foeniculi: cold relieving pain relieving, regulating qi-flowing for harmonizing stomach;
Radix Angelicae Sinensis: QI invigorating regulating menstruation, promoting blood circulation and stopping pain, loosening bowel to relieve constipation;
Fructus Amomi Rotundus: circulation of qi promoting is antipruritic, the removing dampness painful abdominal mass that disappears, stomach warming preventing or arresting vomiting;
Radix Rehmanniae Preparata: enrich blood, the nourishing kidney nourishing YIN;
Rhizoma Drynariae: mend the bone tooth strengthening and pain stopping, muscles and bones the curing the wound of invigorating blood circulation;
Herba Cistanches: kidney invigorating and YANG supporting, intestine moistening is active;
Semen Raphani: intestinal stasis relieving helps digestion, and expectorant will gasify;
Rhizoma Chuanxiong: the up medicine of upper half of human body;
Herba Pyrolae: nourishing liver, invigorating kidney, bone and muscle strengthening, expelling wind and removing dampness;
Caulis Spatholobi: promoting the circulation of blood is enriched blood, relaxing muscles and tendons and activating QI and blood in the collateral;
Herba Epimedii: kidney invigorating and YANG supporting, expelling wind and removing dampness;
Rhizoma Dioscoreae: spleen reinforcing antidiarrheal, support the lung kidney tonifying, supplementing the kidney to control the nocturnal, YIN nourishing and the production of body fluid promoting;
Radix Paeoniae Rubra: removing heat from blood and promoting blood circulation, stasis-dispelling and pain-killing;
Semen Persicae: the removing blood stasis with potent drugs promoting the circulation of blood, moisturize analgesic therapy;
Radix Notoginseng powder: hemostasia and dissipation blood stasis, secondary analgesic therapy disappears;
Squama Manis: detumescence and apocenosis, the meridian dredging;
Radix Cyathulae: promoting blood circulation to restore menstrual flow, Shujin reason spleen.
The specific embodiment
Embodiment 1: a kind of Chinese medicine preparation for the treatment of hyperosteogeny is to cross 300 mesh sieves with the raw material of following weight portion through screening, cleaning and pulverizing back to make the watered pill:
Cortex Lycii 20, the Cortex Eucommiae 25, Fructus Foeniculi 20, Radix Angelicae Sinensis 25, Fructus Amomi Rotundus 10, Radix Rehmanniae Preparata 65, Rhizoma Drynariae 20, Herba Cistanches 25, Semen Raphani 10, Rhizoma Chuanxiong 25, Herba Pyrolae 20, Caulis Spatholobi 65, Herba Epimedii 15, Rhizoma Dioscoreae 40, Radix Paeoniae Rubra 15, Semen Persicae 25, Radix Notoginseng powder 10, Squama Manis 20, Radix Cyathulae 15.
Embodiment 2: a kind of Chinese medicine preparation for the treatment of hyperosteogeny is to cross 300 mesh sieves with the raw material of following weight portion through screening, cleaning and pulverizing back to make capsule:
Cortex Lycii 40, the Cortex Eucommiae 15, Fructus Foeniculi 40, Radix Angelicae Sinensis 15, Fructus Amomi Rotundus 20, Radix Rehmanniae Preparata 35, Rhizoma Drynariae 40, Herba Cistanches 15, Semen Raphani 20, Rhizoma Chuanxiong 15, Herba Pyrolae 40, Caulis Spatholobi 35, Herba Epimedii 25, Rhizoma Dioscoreae 20, Radix Paeoniae Rubra 25, Semen Persicae 15, Radix Notoginseng powder 16, Squama Manis 10, Radix Cyathulae 25.
Embodiment 3: a kind of Chinese medicine preparation for the treatment of hyperosteogeny, be with the raw material of following weight portion through screening, clean and pulverize the back and cross 300 mesh sieves and make powder and take after mixing it with water:
Cortex Lycii 30, the Cortex Eucommiae 20, Fructus Foeniculi 30, Radix Angelicae Sinensis 20, Fructus Amomi Rotundus 15, Radix Rehmanniae Preparata 50, Rhizoma Drynariae 30, Herba Cistanches 20, Semen Raphani 15, Rhizoma Chuanxiong 20, Herba Pyrolae 30, Caulis Spatholobi 50, Herba Epimedii 20, Rhizoma Dioscoreae 30, Radix Paeoniae Rubra 20, Semen Persicae 20, Radix Notoginseng powder 13, Squama Manis 15, Radix Cyathulae 20.
The present invention is applied to clinical treatment final report
The present invention prescription is applied to clinically amount to 4 years and have a surplus, accept patient's 289 examples altogether for medical treatment, the patient uses Western medicine, mid-term to use the treatment of physiotherapys such as acupuncture, massage and traction all ineffective mostly early stage, and all makes a definite diagnosis and determined the position of hyperosteogeny by X-ray or CT.Equal symptom is significantly improved after using Drug therapy of the present invention.
One, case
Patient's 289 examples, the oldest 72 years old, minimum 36 years old, male 127 people wherein, women 162 people.The elder of sick time 29 years, the shortest person one month.
Two, diagnosis
The clinical symptoms of hyperosteogeny is different according to the position difference, but all shows as the unusual pain of disease sites, and makes a definite diagnosis with X-ray or CT.
Three, Therapeutic Method
According to patient's custom of taking medicine prescription of the present invention is made capsule, powder or honeyed pill, take the consumption that is equivalent to crude drug 6 gram at every turn, take every day three times, serious patient is made externally dressing behind the adding Moschus simultaneously use simultaneously in this prescription.After taking 12 days continuously, the patient that clinical symptoms obviously alleviates uses externally dressing instead, improves not obvious patient and continues oral 12 days.
Four, curative effect judging standard and statistical result
The curative effect judging standard that the inventor drafts is also made a definite diagnosis with X-ray or CT examination for meeting outside following three standards.
Cure: the hypertrophy position does not have pain, and joint motion is unrestricted.
Produce effects: hypertrophy position pain is eased, and the joint motion part is limited.
Invalid: clinical symptoms does not alleviate.
Curative effect statistical result is as follows after begin to take medicine 30 days:
Hyperosteogeny position patient's number is cured the invalid effective percentage of produce effects
Cervical spondylosis 113 89 17 7 93.8%
Lumbar vertebra hyperosteogeny 97 91 42 97.9%
Knee joint bony spur 11 920 100%
Spur in heels 60 51 72 96.7%
Elbow hyperosteogeny 8710 100%
Find out that from the statistical result of this table the present invention reaches 96.2% for the treatment total effective rate of hyperosteogeny.

Claims (2)

1. Chinese medicine preparation for the treatment of hyperosteogeny is characterized in that forming with the raw material of following weight portion:
Cortex Lycii 20-40, Cortex Eucommiae 15-25, Fructus Foeniculi 20-40, Radix Angelicae Sinensis 15-25, Fructus Amomi Rotundus 10-20, Radix Rehmanniae Preparata 35-65, Rhizoma Drynariae 20-40, Herba Cistanches 15-25, Semen Raphani 10-20, Rhizoma Chuanxiong 15-25, Herba Pyrolae 20-40, Caulis Spatholobi 35-65, Herba Epimedii 15-25, Rhizoma Dioscoreae 20-40, Radix Paeoniae Rubra 15-25, Semen Persicae 15-25, Radix Notoginseng powder 10-16, Squama Manis 10-20, Radix Cyathulae 15-25.
2. the Chinese medicine preparation of treatment hyperosteogeny according to claim 1 is characterized in that forming with the raw material of following weight portion:
Cortex Lycii 25-35, Cortex Eucommiae 18-22, Fructus Foeniculi 25-35, Radix Angelicae Sinensis 18-22, Fructus Amomi Rotundus 13-17, Radix Rehmanniae Preparata 45-55, Rhizoma Drynariae 25-35, Herba Cistanches 18-22, Semen Raphani 13-17, Rhizoma Chuanxiong 18-22, Herba Pyrolae 25-35, Caulis Spatholobi 45-55, Herba Epimedii 18-22, Rhizoma Dioscoreae 25-35, Radix Paeoniae Rubra 18-22, Semen Persicae 18-22, Radix Notoginseng powder-15, Squama Manis 13-17, Radix Cyathulae 18-22.
CNB2006100427267A 2006-04-21 2006-04-21 Preparation of Chinese traditional medicine for treating hyperosteogeny Expired - Fee Related CN100396321C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100427267A CN100396321C (en) 2006-04-21 2006-04-21 Preparation of Chinese traditional medicine for treating hyperosteogeny

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100427267A CN100396321C (en) 2006-04-21 2006-04-21 Preparation of Chinese traditional medicine for treating hyperosteogeny

Publications (2)

Publication Number Publication Date
CN1872310A CN1872310A (en) 2006-12-06
CN100396321C true CN100396321C (en) 2008-06-25

Family

ID=37483018

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100427267A Expired - Fee Related CN100396321C (en) 2006-04-21 2006-04-21 Preparation of Chinese traditional medicine for treating hyperosteogeny

Country Status (1)

Country Link
CN (1) CN100396321C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101194985B (en) * 2007-12-17 2010-06-09 商昌军 Orally taken Chinese medicine composition for treating articulatio genus hyperosteogeny
CN102920887A (en) * 2012-11-29 2013-02-13 广西梧州三鹤药业有限公司 Chinese medicinal composition for treating hyperostosis
CN104587059A (en) * 2015-02-02 2015-05-06 范晓华 Muscles and tendons relaxing and collaterals obstruction removing tincture for treatment of proliferative osteoarthritis and preparation method thereof
CN105168758A (en) * 2015-11-03 2015-12-23 孙熙 Medicine for treating hyperostosis
CN105748834A (en) * 2016-05-12 2016-07-13 雷世昌 Traditional Chinese medicinal hot-compress composition for promoting recovery of hyperosteogeny

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
中药治疗骨质增生症临床应用分析. 周建伟,张凡.中国骨伤,第11卷第5期. 1998
中药治疗骨质增生症临床应用分析. 周建伟,张凡.中国骨伤,第11卷第5期. 1998 *

Also Published As

Publication number Publication date
CN1872310A (en) 2006-12-06

Similar Documents

Publication Publication Date Title
CN100361704C (en) Medicated wine for treating rheumatosis and osteoarthropathy
CN103349753B (en) Traditional Chinese medicine composition for treating kidney deficiency
CN101766773A (en) Chinese medicine prescription for treating talagia
CN100396321C (en) Preparation of Chinese traditional medicine for treating hyperosteogeny
CN102247497A (en) Chinese patent medicine for treating rheumatoid arthritis
CN1970045B (en) Externally applied Chinese medicine for treating cervical and lumbar spondylosis
CN101664455B (en) Chinese medicinal composition for treating lumbago and preparation method
CN100352465C (en) Medicinal liquor for treating rheumatic arthrolithiasis and its preparing method
CN104013769A (en) Traditional Chinese medicine oral solution for treating osteoporosis
CN102008698A (en) Traditional Chinese medicine composition and preparation for curing dysmenorrhea
CN103800489A (en) Traditional Chinese medicine wine for treating cervical spondylosis and preparation method of traditional Chinese medicine wine
CN101721651B (en) Traditional Chinese medicine capsule for treating scapulohumeral periarthritis
CN102188540B (en) External liniment for treating cervical vertebra and lumbar vertebra diseases
CN104784614A (en) Traditional Chinese medicine composition for treating kidney deficiency
CN102028835B (en) Chinese medicinal composition for treating fracture
CN100542583C (en) A kind of pharmaceutical composition for the treatment of vertebra and arthropathy
CN104306848A (en) Traditional Chinese medicinal composition for treating frequent micturition caused by deficiency of kidney
CN102579672A (en) Medicament for treating bone hyperplasia and lumbar disc herniation
CN102038930A (en) Medicament for treating protrusion of lumbar vertebral disc
CN101703716A (en) Chinese medicinal preparation for treating polyneuritis
CN101040985A (en) Chinese traditional medicine compound took orally for treating osteonecrosis
CN104800443A (en) Bone setting agent with functions of tonifying kidney and regenerating bone marrow
CN103110742A (en) Chinese medicine preparation for treating sciatica
CN102614313A (en) Externally applied Chinese medicine spray for curing scapulohumeral periarthritis
CN102416053A (en) Medicinal moxaroll for treating sciatica and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080625